Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Castle Biosciences Inc
Accumulated Depreciation Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Accumulated Depreciation
-$11.5m
CAGR 3-Years
-64%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Accumulated Depreciation
-$6.2B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-12%
Quest Diagnostics Inc
NYSE:DGX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Castle Biosciences Inc's Accumulated Depreciation?
Accumulated Depreciation
-11.5m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Accumulated Depreciation amounts to -11.5m USD.

What is Castle Biosciences Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-60%

Over the last year, the Accumulated Depreciation growth was -59%. The average annual Accumulated Depreciation growth rates for Castle Biosciences Inc have been -64% over the past three years , -60% over the past five years .

Back to Top